The program will be packed with papers on biochromatography, downstream processing, QbD, monoclonal
antibodies, plasmids, enzymes, vaccines, viral vectors for
gene delivery, VLPs, and other biopharmaceuticals, chiral molecules, SFC, fine chemicals, peptides, proteins, oligonucleotides, APIs, natural products, batch, multi-column and continuous SMB processes, column technology and equipment, monoliths, new and improved stationary phases, membrane chromatography, regulatory aspects, and more!
The lab is developing a novel
gene delivery system to produce anti-tumor and immunomodulatory
antibodies in vivo for cancer treatment.